Latest CV Research Highlighted at ACC Asia Pacific Conference The ACC, in collaboration with the China Cardiovascular Association, brought together top experts to discuss and review new, relevant cardiovascular science pertinent to the Asia Pacific region as part of its 2017 Asia Pacific Conference in Shanghai. The conference provided a platform for cardiovascular professionals to increase their knowledge on key topics such as heart failure, acute coronary syndromes, cardiovascular disease prevention and more. In addition, participants had access to leadership training, tips on how to publish research and time to test their skills in a Learning Lab. Journal of the American College of Cardiology Editor-in-Chief Valentin Fuster, MD, PhD, MACC; ACC Chief Innovation Officer John Rumsfeld, MD, FACC; and ACC Asia Pacific Conference co-chairs Harlan Krumholz, MD, SM, FACC, and Ge Junbo, MD, FACC, were noted plenary speakers at the conference. Aaron D. Kugelmass, MD, FACC, also served as a co-chair of the conference. “It is important for the global cardiovascular community to collaborate on research, best practices and education,” said Krumholz. “Through partnering with the China Cardiovascular Association, this conference offers original, educational content that is locally relevant while providing a venue from us to learn from each other.” In addition to scientific sessions, abstracts featuring research from across the region were also presented as posters. Topics ranged from Readmission after Acute Myocardial Infarction in China” to Visceral Fat-Derived Exosomes Contribute to Obesity-Related Cardiovascular Diseases.” “It is a great honor that the first ACC Asia Pacific Conference [was] held in sahangai China. We have given this meeting the highest Priorty and full support,” said Junbo. “ I believe the ACC’s advanced scientific ideas, combined with the latest guidelines, enable doctors from China and other Asian countries to improve the quality of their care.” Innovation Policy the Focus of ACC Roundtable Identifying hurdles to research and innovation in cardiovascular care was the focus of a recent ACC-hosted roundtable co-chaired by former ACC President Patrick O’Gara, MD, MACC, and William Borden, MD, FACC. The day-long event brought together a diverse group of stakeholders representing government agencies, health systems, patients and industry to identify possible innovative policy solutions to improve patient-centered health outcomes. As part of the event, David Blumenthal, MD, MPP, president of the Commonwealth Fund and former National Coordinator for Health Information Technology, provided personal insights into the development of the HITECH Act of 2009, as well as systemic factors affecting fluidity of digital data in research and potential paths forward. In addition, interactive discussions focused on how to address the challenges posed by data privacy and ownership, interoperability and U.S. Food and Drug Administration regulation of digital health and other such laws and regulations. Outcomes from the Roundtable – intended as a follow-up to the ACC’s 2016 Innovation Summit and the 2017 Innovation Roadmap published in the Journal of the American College of Cardiology – will be used to inform that ACC’s Advocacy efforts in these specific areas going forward. Global NCD Alliance Forum Convenes in UAE; Amplifies Commitment to Lowering NCD Impact More than 300 representatives from governments, multilateral organizations, academia and other stakeholder groups, including the ACC, gathered in Sharjah, UAE, for the second annual Global NCD Alliance Forum. ACC President Mary N. Walsh, MD, FACC, and Thomas Gaziano, MD, FACC, World Heart Federation Partners Council Chair, represented the College at the meeting, which focused on how to globally address noncommunicable disease (NCD). Gaziano participated in a panel that addressed the Action Plan for the Prevention and Control of NCDs 2013–2020, with its different policy options across the four NCD risk factors and four disease areas like cardiovascular diseases, diabetes, cancers and chronic respiratory diseases. The Forum offered an opportunity for stakeholders to come together and discuss NCDs prior to the upcoming 2018 UN General Assembly High-level Meeting on the subject. NCDs continue to be responsible for 70 percent of deaths worldwide, and much of the resulting death could be prevented by modifying unhealthy diets, tobacco use, alcohol use and physical inactivity. Current data suggest that while progress has been made over the last several years, still less than half of all countries have existing plans to fight NCDs on a national level, and current trends suggest that many countries are not on course to meet the global goal of reduce premature and avoidable deaths from NCDs by 25 percent by 2025 (25x25). Meanwhile, a detailed review of the cardiovascular disease-related global health policy recommendations recently put forth by the National Academies of Sciences, Engineering and Medicine echoes the NCD Alliance’s call to prioritize resources toward treating NCDs and maps out the future role the U.S. could play in the global health landscape. I believe the ACC’s advanced scientific ideas, combined with the latest guidelines, enable doctors from China and other Asian countries to improve the quality of their care. NCDs continue to be responsible for 70 percent of deaths worldwide, and much of the resulting death could be prevented by modifying unhealthy diets, tobacco use, alcohol use and physical inactivity.
Published by American College of Cardiology. View All Articles.
This page can be found at https://bluetoad.com/article/The+Pulse+Of+ACC/2966253/462529/article.html.